MSB 7.69% $1.19 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-185

  1. 2,261 Posts.
    lightbulb Created with Sketch. 367
    I disagree they have provided at least 5 level 2b studies that the treatment works. Thats enough to change clincial practice and get FDA approval in many drugs to date. besides about 20% of medicine is actually properly evidenced based... and that hasnt stopped you cutting people open and poisoning them for years. Not intentionally of course but... human factors
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.